NDC 0641-0367-21 - Dexamethasone Sodium Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-0367
- Requested NDC
- 0641-0367-21
- Package NDCs from labels
- 0641-0367-21, 0641-0367-25
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-04-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Sodium Phosphate - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-04-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate Injection, USP Rx only | REMEDYREPACK INC. | 2026-03-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate - A-S Medication Solutions | A-S Medication Solutions | 2026-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate Injection, USP Rx only | Hikma Pharmaceuticals USA Inc. | 2026-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| DEXAMETHASONE SODIUM PHOSPHATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-23 | HUMAN PRESCRIPTION DRUG LABEL |
| ReadySharp Anesthetics plus Dexamethasone - Terrain Pharmaceuticals | Terrain Pharmaceuticals | 2017-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-0367-21 | Dexamethasone Sodium Phosphate | 1 mL in 1 VIAL | INJECTION | 1 | 21 | |
| 0641-0367-25 | Dexamethasone Sodium Phosphate | 25 in 1 CARTON | INJECTION | 25 | 21 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-0367-21 | ML - Milliliter | 0641-0367 | 0ac648a0-35ec-434c-b33d-1645e8a8cc74 | 1 | 2012-07-24 |
| 0641-0367-25 | ML - Milliliter | 0641-0367 | b7f2dd89-0a90-48e6-ad12-aef4345ecf38 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | The Atlanta Dental Supply Company DBA Advanced Dental Products | 55030c51-250b-4fc2-ba3c-ac38dab7cc8e | 2026-08-10 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Septodont, Inc. | df130310-41db-45df-a214-9da01cf0bf41 | 2026-08-10 | Warnings, Adverse reactions | V13007Z41A |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | ASCLEMED USA INC. | a31b013f-924c-42f8-b8ab-ce60bb8ad7b8 | 2026-08-07 | Warnings, Adverse reactions | ANDA084282 1116927 AI9376Y64P |
| Lidonex | LIDOCAINE HCL, MENTHOL | Aldama Pharmaceuticals, Inc | 365cf19c-70e0-c4e9-e063-6294a90ac428 | 2026-08-07 | Warnings | V13007Z41A |
| Sterile Water | WATER | Cardinal Health 107, LLC | 48d75a7c-8329-48a8-bea0-a8c144ddf637 | 2026-08-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Lidocaine Tattoo Wipe | LIDOCAINE HYDROCHLORIDE | MD Tattoo Company | 369c1d16-597c-e1dc-e063-6394a90a3104 | 2026-08-06 | Warnings | V13007Z41A |
| THE SOLU TION | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE HYDROCHLORIDE | SCALP TECH INC | 58793581-8826-9a74-e063-6294a90a2465 | 2026-08-06 | Warnings | V13007Z41A |
| LIDOCAINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | NDC, Inc. | 937e9341-e604-4ca7-98e1-fc7c659d82e9 | 2026-08-06 | Warnings, Adverse reactions | V13007Z41A |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sagent Pharmaceuticals | 4680d517-ed5a-4137-819c-122ee962a464 | 2026-08-06 | Warnings, Adverse reactions | 1116927 1812194 1812079 AI9376Y64P |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-08-05 | Warnings, Adverse reactions | ANDA080408 0409-4713-42 0409-4713 1737757 1737343 1010900 1010033 1737636 1737763 1010671 1737562 1737566 1737568 05d1a200-9d75-4e48-b14a-5069d4ab816f 3b2dd84e-cee8-4e58-d494-395a65a353a0 V13007Z41A |
| Lidocaine Plantar Relief Roll-On | LIDOCAINE | Guangzhou Liuquanmiao Import & Export Trade Co., Ltd. | 585ccb4b-3bff-39b9-e063-6294a90a0e18 | 2026-08-05 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 9c18eaf1-4a0b-4916-70b2-88a827494711 | 2026-08-05 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 46404c7b-2ea4-e47b-e063-6294a90a779f | 2026-08-03 | Warnings, Adverse reactions | V13007Z41A |
| Metabatone | ARALIA RACEMOSA, AVENA SATIVA, BERBERIS VULGARIS, CAPSICUM ANNUUM, GINKGO BILOBA, PHYTOLACCA DECANDRA, HYPOTHALAMUS SUIS, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, FEL TAURI, HYALURONIDASE, PANCREAS SUIS, PANCREATINUM, PAPAIN, STOMACH (SUIS), L-ALANINE, L- ARGININE, L-CARNITINE, CYSTEINUM, L-GLUTAMINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE, L-METHIONINE, L-ORNITHINE, L-PROLINE, L-SERINE, L-TRYPTOPHAN, L-TYROSINE, L-VALINE, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, IODIUM, | Energique, Inc. | 9510bb76-b717-407d-b9e8-da7743e4cfc8 | 2026-07-31 | Warnings | 451W47IQ8X |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Benco Dental | c5cc87df-df3f-42b8-af84-5f2045d42084 | 2026-07-30 | Warnings, Adverse reactions | V13007Z41A |
| Aspercreme Lidocaine No-Mess plus Lavender | LIDOCAINE HCL | Chattem, Inc. | 3948a3d2-ce04-4703-8709-211e75c9c38d | 2026-07-29 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.